Top compounds associated with response to ACAA2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA momelotinib CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA PF-184 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA tivantinib CTRPv2 pan-cancer AAC 0.19 6e-05
Download CSV